Olympion Therapeftirio General Clinic Of Patras S.A.

At Olympion Therapeftirio General Clinic Of Patras S.A., the Hematology research portfolio focuses on blood cancers and non-malignant blood disorders, with studies in chronic lymphocytic leukemia, follicular lymphoma, multiple myeloma, myelodysplastic syndrome, thalassemia, and anemia. These trials are designed to assess new treatment options, improve disease control, and support better long-term outcomes for patients with complex hematologic conditions.

• Testing new approaches for chronic lymphocytic leukemia and lymphoma
• Evaluating therapies for multiple myeloma and myelodysplastic syndromes
• Studying treatment options for thalassemia and anemia

The work here also includes efforts to improve supportive care, such as reducing transfusion needs and managing treatment-related complications.

In Oncology, the site is involved in studies for non-small cell lung cancer, small cell lung cancer, and breast cancer, including advanced or metastatic disease. Research is centered on comparing new cancer therapies with current standards of care, with the goal of extending survival and delaying disease progression.

• Investigating treatments for advanced lung cancer
• Studying therapy options for metastatic breast cancer
• Assessing whether new combinations can improve overall survival and progression-free survival

This area reflects a strong focus on developing more effective cancer care for patients with difficult-to-treat solid tumors.

The Rheumatology department supports a broad range of trials in immune system diseases, especially systemic lupus erythematosus, Sjögren’s syndrome, and systemic sclerosis. These studies aim to reduce disease activity, ease systemic symptoms, and improve quality of life in chronic autoimmune conditions.

• Exploring new treatments for systemic lupus erythematosus
• Evaluating therapies for Sjögren’s disease and related systemic symptoms
• Testing options for systemic sclerosis and other connective tissue diseases

The research also includes work on immune-related mechanisms, helping advance understanding of how these diseases develop and respond to treatment.

Another important research theme at this hospital clinic in Patras is the study of immune thrombocytopenia, warm autoimmune hemolytic anemia, and neutropenic disorders. Trials in this area are aimed at improving blood cell counts, lowering infection risk, and finding safer ways to manage chronic immune-related blood abnormalities.

• Assessing therapies for chronic immune thrombocytopenia
• Studying treatment for autoimmune hemolytic anemia
• Evaluating care for congenital and acquired neutropenia

These studies are especially relevant for patients who need durable control of symptoms and fewer complications from ongoing disease.